RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

The objective of this study is to conduct post-marketing clinical follow-up of four products: NS, NHE, NHG, and PIR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of acute viral rhinitis, rhinosinusitis, and rhinopharyngitis, while also assessing the benefit/risk ratio of the products.

NCT Number	NCT07383493
Lead Sponsor	University Hospital, Clermont-Ferrand
Conditions	Rhinitis Acute, Rhinitis Viral, Rhinosinusitis Acute, Rhinopharyngitis, Rhinitis, Rhinosinusitis
Enrollment	150 participants
Start Date	2026-02-25
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-15